Home > Insider Trading > Filing (0001140361-24-026871)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1281895	Rocket Pharmaceuticals Inc.	RCKT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1725929	Kinnari Patel	C/O Rocket Pharmaceuticals, Inc. 9 Cedarbrook Drive Cranbury NJ 08512	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-05-14	3,990	$0.00	296,291	No	4	M	Direct
Common Stock	Acquisiton	2024-05-14	5,553	$0.00	301,824	No	4	M	Direct
Common Stock	Acquisiton	2022-02-14	11,970	$0.00	313,794	No	4	J	Direct
Common Stock	Acquisiton	2022-08-12	52,489	$0.00	366,283	No	4	J	Direct
Common Stock	Acquisiton	2023-02-14	38,735	$0.00	405,018	No	4	J	Direct
Common Stock	Disposition	2024-05-16	4,046	$23.35	400,972	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2024-05-14	3,990	$0.00	3,990	$0.00
Common Stock	Restricted Stock Units	Disposition	2024-05-14	5,533	$0.00	5,533	$0.00
Common Stock	Restricted Stock Units	Disposition	2022-02-14	11,970	$0.00	11,970	$0.00
Common Stock	Restricted Stock Units	Disposition	2022-08-12	52,489	$0.00	52,489	$0.00
Common Stock	Restricted Stock Units	Disposition	2023-02-14	38,735	$0.00	38,735	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,970	No	4	M	Direct
38,735	No	4	M	Direct
0	No	4	J	Direct
0	No	4	J	Direct
0	No	4	J	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,675	Indirect	By Spouse
Common Stock	104,927	Indirect	By Adaptive Technology LLC

Footnotes

Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.
Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.
Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.
Represents RSUs initially granted on August 12, 2022, which vest in full on August 12, 2025.
The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.
Each RSU represents a contingent right to receive one share of the Issuer's common stock.